Both in Pharmaceuticals
Bicara Therapeutics vs Ironwood Pharmaceuticals, Inc. -
Over the past year BCAX returned −45.1% and IRWD returned +99.7%; their daily moves had a correlation of 0.10.
BCAX −45.1% IRWD +99.7%Growth of $1, one year, split-adjusted
| Metric | BCAX | IRWD |
|---|---|---|
| Price | $8.96 | $3.50 |
| Market cap | $592.9M | $578.3M |
| Today | +12.99% | +1.16% |
| 1 month | −48.2% | −4.1% |
| 6 months | −61.3% | −25.1% |
| Year to date | −46.8% | +3.9% |
| 1 year | −44.9% | +82.3% |
| Revenue growth (YoY) | — | +32.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 45.4% |
| P/E (TTM) | — | 4.5× |
| Price / sales | — | 1.5× |
| Net cash | $497.3M | -$305.9M |
| Dividend yield | — | — |
| Volatility (60d) | 134.8% | 48.7% |
| Short % of float | 23.9% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).